SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-008838
Filing Date
2020-01-30
Accepted
2020-01-30 17:39:05
Documents
1
Period of Report
2020-01-28

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3083
  Complete submission text file 0001104659-20-008838.txt   4436
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Klein Christopher (Reporting) CIK: 0001755264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 20562529